NASDAQ
Allarity Therapeutics, Inc. (ALLR) has a free cash flow growth of -40.17% as of Friday, May 29, 2026. This represents a 319.93% decrease compared to its 12-month average of -9.57%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.